UBS has reiterated a buy rating on Colgate-Palmolive India, setting a target price of ₹3,000 per share, as it views current cyclical weakness as a buying opportunity with strong long-term structural positioning.
The brokerage noted that Q4 performance remained soft and the near-term outlook is still tepid, but emphasized that Colgate is structurally well-placed to deliver high single-digit growth going forward. UBS believes the company’s strategic positioning has strengthened, supported by its strong brand, product pipeline, and distribution.
Valuation-wise, Colgate trades at 39x FY27 estimated earnings, which UBS said reflects near-term softness but does not fully capture the potential upside over a one-year horizon.
Disclaimer: The views and recommendations above are those of the respective brokerage firm. They do not represent the views of this publication. Investors are advised to consult their financial advisers before making any investment decisions.